These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 1722790)

  • 1. The origin and development of benign prostatic hyperplasia. An age-dependent process.
    Oesterling JE
    J Androl; 1991; 12(6):348-55. PubMed ID: 1722790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benign prostatic hyperplasia: a review of its histogenesis and natural history.
    Oesterling JE
    Prostate Suppl; 1996; 6():67-73. PubMed ID: 8630233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiology and natural history of benign prostatic hyperplasia.
    Barry MJ
    Urol Clin North Am; 1990 Aug; 17(3):495-507. PubMed ID: 1695778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benign prostatic hyperplasia: age-related tissue-remodeling.
    Untergasser G; Madersbacher S; Berger P
    Exp Gerontol; 2005 Mar; 40(3):121-8. PubMed ID: 15763388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Epidemiology and natural course of benign prostatic hyperplasia].
    Blom JH; Schröder FH
    Urologe A; 1992 May; 31(3):129-34. PubMed ID: 1377429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular resistance in the prostate evaluated by colour Doppler ultrasonography: is benign prostatic hyperplasia a vascular disease?
    Berger AP; Horninger W; Bektic J; Pelzer A; Spranger R; Bartsch G; Frauscher F
    BJU Int; 2006 Sep; 98(3):587-90. PubMed ID: 16796699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of systematic prostate biopsy on prostate cancer incidence in men with symptomatic benign prostatic hyperplasia undergoing transurethral resection of the prostate.
    Ornstein DK; Rao GS; Smith DS; Andriole GL
    J Urol; 1997 Mar; 157(3):880-3; discussion 883-4. PubMed ID: 9072591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The chimpanzee as a model of human benign prostatic hyperplasia.
    Steiner MS; Couch RC; Raghow S; Stauffer D
    J Urol; 1999 Oct; 162(4):1454-61. PubMed ID: 10492237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salient and co-morbid features in benign prostatic hyperplasia: a histopathological study of the prostate.
    Shakya G; Malla S; Shakya KN
    Kathmandu Univ Med J (KUMJ); 2003; 1(2):104-9. PubMed ID: 16388207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urologic diseases in America project: benign prostatic hyperplasia.
    Wei JT; Calhoun E; Jacobsen SJ
    J Urol; 2005 Apr; 173(4):1256-61. PubMed ID: 15758764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New insights into the epidemiology and natural history of benign prostatic hyperplasia.
    Boyle P
    Prog Clin Biol Res; 1994; 386():3-18. PubMed ID: 7528398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calculated fast-growing benign prostatic hyperplasia--a risk factor for developing clinical prostate cancer.
    Hammarsten J; Högstedt B
    Scand J Urol Nephrol; 2002; 36(5):330-8. PubMed ID: 12487736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benign prostatic hyperplasia. Its natural history, epidemiologic characteristics, and surgical treatment.
    Oesterling JE
    Arch Fam Med; 1992 Nov; 1(2):257-66. PubMed ID: 1285243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Origin and evolution of benign prostatic enlargement.
    McNeal JE
    Invest Urol; 1978 Jan; 15(4):340-5. PubMed ID: 75197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alpha 1-adrenoceptor antagonists terazosin and doxazosin induce prostate apoptosis without affecting cell proliferation in patients with benign prostatic hyperplasia.
    Chon JK; Borkowski A; Partin AW; Isaacs JT; Jacobs SC; Kyprianou N
    J Urol; 1999 Jun; 161(6):2002-8. PubMed ID: 10332490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The overlooked cause of benign prostatic hyperplasia: prostatic urethral angulation.
    Cho KS; Kim J; Choi YD; Kim JH; Hong SJ
    Med Hypotheses; 2008; 70(3):532-5. PubMed ID: 17761390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histopathologic characterization of hereditary benign prostatic hyperplasia.
    Doehring CB; Sanda MG; Partin AW; Sauvageot J; Juo H; Beaty TH; Epstein JI; Hill G; Walsh PC
    Urology; 1996 Oct; 48(4):650-3. PubMed ID: 8886078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diseases of the prostate in elderly patients. Benign prostate hyperplasia and prostate carcinoma].
    Madersbacher S
    Wien Med Wochenschr; 2001; 151(18-20):430-8. PubMed ID: 11817252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A population based study of incidence and treatment of benign prostatic hyperplasia among residents of Olmsted County, Minnesota: 1987 to 1997.
    Sarma AV; Jacobson DJ; McGree ME; Roberts RO; Lieber MM; Jacobsen SJ
    J Urol; 2005 Jun; 173(6):2048-53. PubMed ID: 15879823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alcohol and the risk of prostate cancer and benign prostatic hyperplasia.
    Crispo A; Talamini R; Gallus S; Negri E; Gallo A; Bosetti C; La Vecchia C; Dal Maso L; Montella M
    Urology; 2004 Oct; 64(4):717-22. PubMed ID: 15491708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.